Abstract:Angiogenesis is one of the most essential events during embryonic development. The previous studies proved that MEKK3 (MAP3K3) is critical for angiogenesis. However, precisely how MEKK3 regulates the vascular development remains largely unknown. To investigate the impact of MEKK3 in vascular development in vivo and its role in normal physiological and pathological settings, we generated VE-Cadherin CreERT2;MEKK3 flox/+ (control) and VE-Cadherin CreERT2;MEKK3 flox/- (MEKK3 iEC -/-) mice. MEKK3 deletion was induced from postnatal day (P) 1 by administration of tamoxifen daily. The retinal angiogenesis model was used to analyze the blood vessel development in P7 and P12 mice. Whole-mount staining of P7 retinas in MEKK3 iEC -/- mutants showed a significant decrease in vascularized area and branch formation. In contrast, control pups, although only having one copy of the MEKK3 gene in endothelial cells, developed a complete vascular sheet at the same dose of tamoxifen, as did the untreated pups. At P12, MEKK3 iEC -/- mice showed defects in vessel remodeling and arterial patterning. These retinas had dilated and tortuous arteries losing the identical marker. This phenotype accorded with the pathology of AVM (arteriovenous malformation). We then cultured murine aortic rings in 3D matrigel and induced sprouting with VEGF. Administration of TGF-b receptor kinase inhibitor SB431542 to the MEKK3 iEC-/- aorta showed a partial rescue effect on the number of sprouts and vascularized area. It implicated that the vascular malformation in the MEKK3 iEC-/- mice was partially due to the elevated TGF-b signals in endothelial cells. We confirmed the result by staining the retinas with SMA and N-cadherin, which are the downstream genes in TGF-b pathway. It turned out that both SMA and N-cadherin were expressed stronger in MEKK3 iEC-/- retinas than in the control ones. Next, by in vitro studies, we found that endothelial cell activation by VEGF treatment led to rapid and strong phosphorylation of R-SMADs at the linker regions in the control endothelial cells. Such phosphorylation was severely impaired in the MEKK3 -/- endothelial cells. The same results were found in the activation of ERK1/2 and p38. Inhibition of ERK1/2 but not p38 MAPK in control endothelial cells greatly reduced the VEGF-induced phosphorylation of R-SMADs at their linker regions. Inhibition of both ERK1/2 and p38 did not further reduce the SMAD linker region phosphorylation compared to inhibition of ERK1/2. Thus, we determined ERK1/2 are responsible for the VEGF-induced, MEKK3-dependent phosphorylation of R-SMADs at the linker region. Finally, since Notch pathway is an evolutionarily conserved signaling , which directly affects angiogenesis, we used aortic ring model to test their interaction, and detected the gene expression in endothelial cells. Hey1 and Hey2 were over expressed in MEKK3 -/- endothelial cells. Knockdown of Hey1 and Hey2 could rescue the deficient angiogenesis. Knockdown of RBPJ did not affect MEKK3 mediated angiogenesis or induction of Hey1 and Hey2. The above data supported a model whereby MEKK3-mediated SMAD signaling induces HEY1 and HEY2 independently of canonical Notch activation. Disclosures No relevant conflicts of interest to declare.

MAP Kinases, Phosphatidylinositol 3-Kinase, and P70 S6 Kinase Mediate the Mitogenic Response of Human Endothelial Cells to Vascular Endothelial Growth Factor.

Involvement of C-Jun N-terminal Kinase and Extracellular Signal-Regulated Kinase 1/2 in EGF-induced Angiogenesis.

Characterization of Vascular Endothelial Growth Factor'S Effect on the Activation of Protein Kinase C, Its Isoforms, and Endothelial Cell Growth

Vascular Endothelial Growth Factor Regulates Endothelial Cell Survival through the Phosphatidylinositol 3′-Kinase/Akt Signal Transduction Pathway

C-Jun N-Terminal Kinase Mediated VEGFR2 Sustained Phosphorylation is Critical for VEGFA-Induced Angiogenesis in Vitro and in Vivo

P38 Mitogen-activated Protein Kinase Mediates Hypoxia-Induced Vascular Endothelial Growth Factor Release in Human Endothelial Cells.

VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells

HB-EGF promotes angiogenesis in endothelial cells via PI3-kinase and MAPK signaling pathways

VEGF Stimulates Activation of ERK5 in the Absence of C-Terminal Phosphorylation Preventing Nuclear Localization and Facilitating AKT Activation in Endothelial Cells

Akt Down-regulation of p38 Signaling Provides a Novel Mechanism of Vascular Endothelial Growth Factor-mediated Cytoprotection in Endothelial Cells*

[Endothelin-Stimulated Proliferation of Thoracic Artery Smooth Muscle Cells Involves Activation of Mitogen-Activated Protein Kinase].

Direct Evidence for Endothelial Vascular Endothelial Growth Factor Receptor-1 Function in Nitric Oxide-Mediated Angiogenesis

[Activation of Signal Transducers and Activators of Transcription Induced by Vascular Endothelial Growth Factor in CD34+ Hematopoietic Progenitor Cells in Vitro].

Vegf Induces Proliferation of Human Hair Follicle Dermal Papilla Cells Through Vegfr-2-Mediated Activation of Erk

Participation of PI3K and ERK1/2 Pathways Are Required for Human Brain Vascular Smooth Muscle Cell Migration

Vascular Smooth Muscle Cell Proliferation Requires Both P38 And Bmk1 Map Kinases

Myc‐dependent Endothelial Proliferation is Controlled by Phosphotyrosine 1212 in VEGF Receptor‐2

Modulation of VEGF-induced endothelial cell cycle protein expression through cyclic AMP hydrolysis by PDE2 and PDE4

MEKK3 Regulates Angiogenesis Through Smad Signaling

Brain Derived Neurotrophic Factor Induces Endothelial Cells Angiogenesis Through AKT and ERK1/2 Signal Pathway.

Hypoxia Enhances FGF2- and VEGF-stimulated Human Placental Artery Endothelial Cell Proliferation: Roles of MEK1/2/ERK1/2 and PI3K/AKT1 Pathways.